May 9, 2018 / 10:50 AM / 6 months ago

BRIEF-Clementia Pharmaceuticals Reports Qtrly Loss Per Share Of $0.42

May 9 (Reuters) - Clementia Pharmaceuticals Inc:

* CLEMENTIA REPORTS FIRST QUARTER 2018 OPERATING RESULTS AND PIPELINE UPDATES

* CLEMENTIA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.42

* CLEMENTIA PHARMACEUTICALS INC - AS OF MARCH 31, 2018, CLEMENTIA HAD CASH AND INVESTMENTS OF $131.6 MILLION. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below